Cross-genus analysis reveals architecturally programmed sgRNA synthesis patterns in coronaviruses.

Publication date: Jul 30, 2026

Coronaviruses employ discontinuous transcription to produce canonical subgenomic RNAs (sgRNAs) essential for gene expression. Although TRS-dependent template switching mechanism has been proposed, its structural basis remains poorly defined, and the functional significance of abundant non-canonical sgRNAs persists as a critical gap since the discovery of discontinuous RNA synthesis. Here, we help bridge this gap through the first cross-genus integrated analysis of coronavirus transcriptomes and RNA interactomes. We show that canonical sgRNA formation is associated with same-direction RNA-RNA interactions. In contrast, non-canonical sgRNAs form through distinct architectural mechanisms: short-range junctions mediated by stem-loop structures overlapping genomic deletion hotspots, and conserved long-range ORF1a-N interactions generating sgRNAs encoding immune-modulatory ORFs – a function not previously attributed to non-canonical transcription. These findings suggest architecturally programmed discontinuous RNA synthesis and highlight a potential link between non-canonical sgRNAs, genomic plasticity, and immune modulation, which may have implications for coronavirus adaptation.

Open Access PDF

Concepts Keywords
Architectural Canonical
Coronaviruses Coronavirus
Discontinuous Coronaviruses
Genomic Cross
Rna Discontinuous
Gap
Genus
Interactions
Non
Programmed
Rna
Sgrna
Sgrnas
Synthesis
Transcription

Semantics

Type Source Name
drug DRUGBANK Lomustine
disease MESH Diarrhea
drug DRUGBANK Esomeprazole
disease MESH EV1
disease MESH coronavirus infection
disease MESH infection
disease MESH hpi
disease MESH strain
disease MESH NHC
disease MESH included
drug DRUGBANK Trestolone
drug DRUGBANK Topiramate
pathway KEGG Viral replication
disease MESH hepatitis
disease MESH arcs
drug DRUGBANK Isoxaflutole
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH recurrence
pathway REACTOME Translation
drug DRUGBANK Formaldehyde
drug DRUGBANK Glycine
drug DRUGBANK Trypsin
drug DRUGBANK Methylergometrine
disease MESH FBS
drug DRUGBANK Streptomycin
drug DRUGBANK Coenzyme M
disease MESH STAR
disease MESH virus infection
drug DRUGBANK Phencyclidine
drug DRUGBANK Biotin
drug DRUGBANK Ademetionine
drug DRUGBANK Ranitidine
drug DRUGBANK Aspartame
drug DRUGBANK Amino acids
drug DRUGBANK Carboxyamidotriazole
pathway KEGG Virion
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Guanosine
disease MESH PMC
drug DRUGBANK Mitomycin
pathway REACTOME Mitophagy
drug DRUGBANK L-Aspartic Acid
disease MESH Plan
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *